News
For technology related news please see here.
Clinical Genomics welcomes Peter Jollie AM to the Board of Directors
- Details
- Reported in January 2012
The Board and Management note the passing of Director Peter Horrobin
- Details
- Reported in July 2011
Clinical Genomics Extends Strategic Alliance for Colorectal Cancer Testing Development with Quest Diagnostics
- Details
- Reported in July 2011
CG presents advance toward the development of a sensitive blood test for colorectal neoplasia at DDW2011 in Chicago
- Details
- Reported in May 2011
Clinical Genomics invited to present at CHI's Early Oncology Partnering Forum
- Details
- Reported in February 2011
Clinical Genomics Presenting at Biomarkers in Diagnostics and Theraputics Conference
- Details
- Reported in January 2011
Clinical Genomics and The Garvan Institute of Medical Research enter into licensing agreement
- Details
- Reported in September 2010
Clinical Genomics continues collaborative research with The Commonwealth Scientific and Industrial Research Organisation (CSIRO)
- Details
- Reported in October 2009
Clinical Genomics Presents Advanced in Bowel Cancer Research at Digestive Disease Week
- Details
- Reported in June 2009
Clinical Genomics Announces Receipt of Milestone Payments from Quest Diagnostics
- Details
- Reported in April 2009
Clinical Genomics Files Patent Applications for Novel Gene Expression Signatures for Colorectal Neoplasia
- Details
- Reported in October 2008
The journal Physiological Genomics accepts for publication Clinical Genomics' original manuscript, "Map of Differential Transcript Expression in the Normal Large Intestine", the first map of gene expression changes across a human organ
- Details
- Reported in December 2007
The Australian patent office grants Clinical Genomics it's first patent protecting ten biomarkers for colorectal neoplasia
- Details
- Reported in November 2007
In collaboration with CSIRO's P-Health Flagship and researchers at Flinders University, Clinical Genomics files a provisional patent to protect an expanded set of candidate biomarkers for colorectal neoplasia
- Details
- Reported in October 2007
Australian Government Awards Clinical Genomics A Commercial Ready Grant Of More Than $1.48 Million Dollars To Exploit Internally Developed Intellectual Property
- Details
- Reported in July 2007
Clinical Genomics enters into a Collaborative Research and Development Agreement with CSIRO's Preventative Health Flagship to research products to improve detection of early-stage colorectal neoplasia
- Details
- Reported in November 2006
Clinical Genomics is founded to expand and commercialise a proprietary set of candidate biomarkers for colorectal neoplasia purchased from Enterix Inc following that company's merger with Quest Diagnostics
- Details
- Reported in September 2006
